291 related articles for article (PubMed ID: 28767711)
1. Progress towards a public chemogenomic set for protein kinases and a call for contributions.
Drewry DH; Wells CI; Andrews DM; Angell R; Al-Ali H; Axtman AD; Capuzzi SJ; Elkins JM; Ettmayer P; Frederiksen M; Gileadi O; Gray N; Hooper A; Knapp S; Laufer S; Luecking U; Michaelides M; Müller S; Muratov E; Denny RA; Saikatendu KS; Treiber DK; Zuercher WJ; Willson TM
PLoS One; 2017; 12(8):e0181585. PubMed ID: 28767711
[TBL] [Abstract][Full Text] [Related]
2. The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.
Wells CI; Al-Ali H; Andrews DM; Asquith CRM; Axtman AD; Dikic I; Ebner D; Ettmayer P; Fischer C; Frederiksen M; Futrell RE; Gray NS; Hatch SB; Knapp S; Lücking U; Michaelides M; Mills CE; Müller S; Owen D; Picado A; Saikatendu KS; Schröder M; Stolz A; Tellechea M; Turunen BJ; Vilar S; Wang J; Zuercher WJ; Willson TM; Drewry DH
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429995
[TBL] [Abstract][Full Text] [Related]
3. Predicting kinase inhibitors using bioactivity matrix derived informer sets.
Zhang H; Ericksen SS; Lee CP; Ananiev GE; Wlodarchak N; Yu P; Mitchell JC; Gitter A; Wright SJ; Hoffmann FM; Wildman SA; Newton MA
PLoS Comput Biol; 2019 Aug; 15(8):e1006813. PubMed ID: 31381559
[TBL] [Abstract][Full Text] [Related]
4. Protocols for the Design of Kinase-focused Compound Libraries.
Jacoby E; Wroblowski B; Buyck C; Neefs JM; Meyer C; Cummings MD; van Vlijmen H
Mol Inform; 2018 May; 37(5):e1700119. PubMed ID: 29116686
[TBL] [Abstract][Full Text] [Related]
5. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
6. Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases.
Duong-Ly KC; Devarajan K; Liang S; Horiuchi KY; Wang Y; Ma H; Peterson JR
Cell Rep; 2016 Feb; 14(4):772-781. PubMed ID: 26776524
[TBL] [Abstract][Full Text] [Related]
7. Developing a Kinase Chemogenomic Set: Facilitating Investigation into Kinase Biology by Linking Phenotypes to Targets.
Wells CI; Drewry DH
Methods Mol Biol; 2023; 2706():11-24. PubMed ID: 37558938
[TBL] [Abstract][Full Text] [Related]
8. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review.
Liang C; Tian D; Ren X; Ding S; Jia M; Xin M; Thareja S
Eur J Med Chem; 2018 May; 151():315-326. PubMed ID: 29631132
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
10. Selective and potent small-molecule inhibitors of PI3Ks.
Jeong Y; Kwon D; Hong S
Future Med Chem; 2014 May; 6(7):737-56. PubMed ID: 24941870
[TBL] [Abstract][Full Text] [Related]
11. Kinome-Wide Profiling Prediction of Small Molecules.
Sorgenfrei FA; Fulle S; Merget B
ChemMedChem; 2018 Mar; 13(6):495-499. PubMed ID: 28544552
[TBL] [Abstract][Full Text] [Related]
12. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
Ravikumar B; Timonen S; Alam Z; Parri E; Wennerberg K; Aittokallio T
Cell Chem Biol; 2019 Nov; 26(11):1608-1622.e6. PubMed ID: 31521622
[TBL] [Abstract][Full Text] [Related]
13. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
[TBL] [Abstract][Full Text] [Related]
14. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
15. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
Fabbro D
Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
[TBL] [Abstract][Full Text] [Related]
16. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
Miljković F; Bajorath J
J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
[TBL] [Abstract][Full Text] [Related]
17. Light-assisted small-molecule screening against protein kinases.
Inglés-Prieto Á; Reichhart E; Muellner MK; Nowak M; Nijman SM; Grusch M; Janovjak H
Nat Chem Biol; 2015 Dec; 11(12):952-4. PubMed ID: 26457372
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Covalent Kinase Inhibitor from a DNA-Encoded Small-Molecule Library × Protein Library Selection.
Chan AI; McGregor LM; Jain T; Liu DR
J Am Chem Soc; 2017 Aug; 139(30):10192-10195. PubMed ID: 28689404
[TBL] [Abstract][Full Text] [Related]
19. How to Prepare a Compound Collection Prior to Virtual Screening.
Bologa CG; Ursu O; Oprea TI
Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.
Chaudhary D; Robinson S; Romero DL
J Med Chem; 2015 Jan; 58(1):96-110. PubMed ID: 25479567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
